© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#etravirine

Many People With HIV Could Switch to Newer, Safer Regimens

A majority of people taking antiretrovirals to treat HIV could switch to newer regimens with improved side effect profiles.

HIV Meds Much Cheaper Globally, Unless They’re Newer Drugs

Global prices for first- and second-line HIV therapies have plummeted, but newer therapies are still hugely expensive.

FDA Updates the Labels of Intelence (Etravirine) and Prezista (Darunavir)

The U.S. Food and Drug Administration has approved changes to the labels for the antiretrovirals (ARVs) Intelence (etravirine) and Prezista (d...

Second-Generation Non-Nuke Approved for Children 6 and Older

Children between 6 and 17 years old may now use Intelence, a non-nucleoside reverse transcriptase inhibitor (NNRTI) that has shown to be...

Isentress, Intelence, Prezista Regimen Goes the Distance for HIV Treatment Veterans

A drug regimen containing Isentress (raltegravir), Intelence (etravirine) and Norvir (ritonavir)–boosted Prezista (darunavir)...

After 2 Years, Drug Regimen Works Well Among Treatment-Experienced

A drug regimen containing Isentress (raltegravir), Intelence (etravirine) and Norvir (ritonavir)?boosted Prezista (darunavir) continues to wor...

New One Pill, Twice Daily Dosing for HIV Non-Nuke Intelence

Good news for Intelence (etravirine) users: Instead of two 100 milligram (mg) tablets twice a day, the recent approval of a 200 mg tablet will...

Switch From Efavirenz to Intelence Improves Side Effects in Some

People on a regimen containing efavirenz (found in Sustiva and Atripla) who have neurological side effects or abnormal cholesterol or triglyce...

Switch From Sustiva to Intelence Reduces Central Nervous System Side Effects

People with central nervous system (CNS) side effects, who switched from Sustiva (efavirenz) plus two nucleoside reverse transcriptase inhibit...

A Slower Response to HIV Treatment Is Just as Good as a Fast Response

People whose HIV levels drop more slowly after starting antiretroviral (ARV) therapy do just as well over two years as people whose virus drop...

Tip Sheet

The HIV non-nuke Intelence (etravirine) is uncoated, very lightweight and quick to dissolve. 

Intelence Receives Full FDA Approval

The U.S. Food and Drug Administration (FDA) has granted full approval to the non-nucleoside reverse transcriptase inhibitor (NNRTI)...

Medicine Chest

HIV Drug News

New Intelence Prescribing Information Warns of Severe Rash Risk

The prescribing information for Intelence (etravirine) has been updated to reflect warnings of rare—but potentially life-threatening—skin....

Triple-Drug Regimen Works Well for Heavily Treatment-Experienced Patients

A drug regimen containing Isentress (raltegravir), Intelence (etravirine) and Norvir (ritonavir)?boosted Prezista (darunavir) continues to wor...

Looking Back, Moving Forward: The Year in Treatment News

A new non-nuke, the apparent cure of an HIV-positive patient receiving a bone marrow transplant and the possibility of earlier...
Advertisement